Most investment firms measure their strategies obsessively and their research process not at all. Performance dashboards track every position, yet the machinery that produced those positions runs unexamined. At Bountify we take the opposite view. Because strategies are perishable and the process that generates them is not, the process deserves the better instrumentation. We run research the way an engineer runs a production line: measured, versioned, and accountable to its own metrics.
What the Instrument Panel Shows
The core gauges are simple to state and demanding to maintain. How many hypotheses were tested this week? What fraction survived each stage of validation, from causal backtest through out-of-sample evaluation to paper trading? How long does an idea wait between conception and verdict? These numbers describe throughput, yield and latency, the same quantities any serious factory manager would watch, applied here to the manufacture of trading strategies.
Survival rates deserve particular attention because they encode the honesty of the whole system. A pipeline that passes nearly everything is not rigorous; a pipeline that passes nearly nothing is generating poor hypotheses. Each stage kills for a different reason, and the distribution of causes of death is itself informative. Watching how the survival curve shifts as we tighten criteria or introduce new data tells us more about research health than any single strategy result ever could.
Live Versus Backtest: The Scoreboard That Cannot Be Argued With
The most important gauge compares what strategies did in simulation with what they do in live markets. We measure this tracking error strategy by strategy and, more importantly, in aggregate across cohorts. If live results systematically undershoot backtests, something upstream is broken: leakage in the data, optimism in the cost model, or selection bias the corrections failed to catch. The aggregate gap between simulated and realized performance is the single best audit of the entire factory.
The Process Is the Durable Asset
Any individual strategy will decay; that is the nature of edges in competitive markets. A repeatable, instrumented process that keeps producing validated strategies is a different kind of asset entirely, one that compounds rather than depreciates. This is why we treat research velocity as an institutional discipline rather than a vanity metric, and why every improvement we make targets the system itself, not the star performer of the quarter.
Instrumentation changes behavior. When hypotheses tested, survival rates and idea-to-verdict latency are visible on a wall, research stops being a sequence of heroic discoveries and becomes an operating rhythm. The factory does not promise that any given week produces a winner. It promises that the machine that finds winners is running, measured and improving, which is the only promise a quantitative research organization can honestly make.